Brief: Xbrane Biopharma Q4 EBITDA Loss Widens To SEK 30.3 Mln

Xbrane Biopharma AB

22/02/2019 07:16

Feb 22 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * Q4 REVENUE AMOUNTED TO SEK 4,896 THOUSAND (9,535).
    * Q4  EBITDA AMOUNTED TO SEK-30,336 THOUSAND (-17,992)

Source text for Eikon:  ID:nGNE2Z2QYm 
Further company coverage:  XBRANE.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))